Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis

被引:19
|
作者
Nakata, R. [1 ]
Motomura, M. [1 ]
Masuda, T. [1 ]
Shiraishi, H. [1 ]
Tokuda, M. [1 ]
Fukuda, T. [1 ]
Ando, T. [1 ]
Yoshimura, T. [1 ]
Tsujihata, M. [2 ,3 ]
Kawakami, A. [1 ]
机构
[1] Nagasaki Univ, Dept Clin Neurosci & Neurol, Grad Sch Biomed Sci, Nagasaki 8528501, Japan
[2] Nagasaki Univ, Sch Hlth Sci, Nagasaki 8528501, Japan
[3] Nagasaki Kita Hosp, Nagasaki, Japan
关键词
associated autoimmune disease; muscle-specific receptor tyrosine kinase; myasthenia gravis; thymus; titin antibodies; TITIN ANTIBODIES; ACETYLCHOLINE-RECEPTORS; MYOID CELLS; MUSK; AUTOANTIBODIES; THYMOMA; HETEROGENEITY; FEATURES; MG;
D O I
10.1111/ene.12169
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: The differences in the characteristics of thymus histology, coexisting autoimmune diseases and related autoantibodies between anti-muscle-specific receptor tyrosine kinase (MuSK)-antibody (Ab)-positive myasthenia gravis (MG) patients, and anti-acetylcholine receptor (AChR)-Ab-positive MG patients are not clearly defined. Methods: The types of thymus histology, coexisting autoimmune diseases and associated Abs in 83 MuSK-Ab-positive patients nationwide were investigated and were compared with those in AChR-Ab-positive patients followed at our institute (n = 83). As for the autoantibodies associated with thymoma, titin Abs were measured. Results: Thymoma was not present in any of the MuSK-Ab-positive patients but presented in 21 patients (25.3%) amongst the AChR-Ab-positive patients. Titin Abs were absent in MuSK-Ab-positive patients but positive in 25 (30.1%) of the AChR-Ab-positive patients. Concomitant autoimmune diseases were present in eight MuSK-Ab-positive patients (9.6%) amongst whom Hashimoto's thyroiditis and rheumatoid arthritis predominated, whereas 22 AChR-Ab-positive patients (26.5%) had one or more concomitant autoimmune diseases of which Graves' disease predominated. Conclusions: Differences in frequency of thymoma and thymic hyperplasia, coexisting autoimmune diseases and autoantibody positivity between MuSK-Ab-positive and AChR-Ab-positive MG were indicated, suggesting that, in contrast with AChR-Ab-positive MG, thymus does not seem to be involved in the pathogenic mechanisms of MuSK-Ab-positive MG.
引用
收藏
页码:1272 / 1276
页数:5
相关论文
共 50 条
  • [41] IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients
    Koneczny, Inga
    Stevens, Jo A. A.
    De Rosa, Anna
    Huda, Saif
    Huijbers, Maartje G.
    Saxena, Abhishek
    Maestri, Michelangelo
    Lazaridis, Konstantinos
    Zisimopoulou, Paraskevi
    Tzartos, Socrates
    Verschuuren, Jan
    van der Maarel, Silvere M.
    van Damme, Philip
    De Baets, Marc H.
    Molenaar, Peter C.
    Vincent, Angela
    Ricciardi, Roberta
    Martinez-Martinez, Pilar
    Losen, Mario
    JOURNAL OF AUTOIMMUNITY, 2017, 77 : 104 - 115
  • [42] Patient autoantibodies deplete postsynaptic muscle-specific kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice
    Cole, R. N.
    Ghazanfari, N.
    Ngo, S. T.
    Gervasio, O. L.
    Reddel, S. W.
    Phillips, W. D.
    JOURNAL OF PHYSIOLOGY-LONDON, 2010, 588 (17): : 3217 - 3229
  • [44] Successful Transition from Plasma Exchange to Eculizumab in Acetylcholine Receptor Antibody- and Muscle-Specific Kinase (MuSK) Antibody-Negative Myasthenia Gravis: A Case Report
    Greenwood, Gregory T.
    Lynch, Zachary
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21
  • [45] CLINICAL PERFORMANCE OF DIFFERENT TESTING PLATFORMS FOR DETECTION OF ACETYLCHOLINE-RECEPTOR AND MUSCLE-SPECIFIC KINASE ANTIBODIES IN MYASTHENIA GRAVIS
    Kumar, Pankaj
    Sodhi, Harvir
    Kihara, Eve
    Kaur, Navpreet
    Mousavi, Ali
    Aziz, Tariq
    Shyu, Clay
    Frykman, Hans
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S153 - S153
  • [46] Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)
    Cebi, M.
    Durmus, H.
    Yilmaz, V
    Yentur, S. P.
    Aysal, F.
    Oflazer, P.
    Parman, Y.
    Deymeer, F.
    Saruhan-Direskeneli, G.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2019, 197 (02) : 214 - 221
  • [47] Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: A case report and literature review
    Sylvester, Jessica
    Purdie, Grant
    Slee, Mark
    Gray, James X.
    Burnet, Simon
    Koblar, Simon
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 264 (1-2) : 130 - 133
  • [48] Anti-Muscle-Specific Kinase (MuSK) Antibody-Positive Myasthenia Gravis Presenting With Dyspnea in an Elderly Woman: A Case Report
    Shiozumi, Tadaharu
    Okada, Nobunaga
    Matsuyama, Tasuku
    Yamahata, Yoshihiro
    Ohta, Bon
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [49] Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study
    Habib, Ali A.
    Sacconi, Sabrina
    Antonini, Giovanni
    Cortes-Vicente, Elena
    Grosskreutz, Julian
    Mahuwala, Zabeen K.
    Mantegazza, Renato
    Pascuzzi, Robert M.
    Utsugisawa, Kimiaki
    Vissing, John
    Vu, Tuan
    Wiendl, Heinz
    Boehnlein, Marion
    Greve, Bernhard
    Woltering, Franz
    Bril, Vera
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
  • [50] Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study
    Tan, Ying
    Shi, Jiayu
    Huang, Yangyu
    Li, Ke
    Yan, Jingwen
    Zhu, Li
    Guan, Yuzhou
    Cui, Liying
    FRONTIERS IN NEUROLOGY, 2022, 13